Munitions experts said the video appeared to show a Tomahawk strike near the school in Minab, where scores of children were killed last month, according to Iranian officials.

OpenAI has released its Codex desktop app for Windows, adding a native sandbox and PowerShell support, enabling developers to ...

Students said the idea for the project started about two years ago. BBC hits back in Trump's $10 billion lawsuit US judge throws out immigration board's ruling endorsing Trump mass detention policy ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

FAIRBORN — Wright State University has earned full membership in the U.S. Space Command’s Academic Engagement Enterprise, becoming the third Ohio institution and the 89th across the country to earn ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Forbes contributors publish independent expert analyses and insights. Ron Schmelzer covers AI and data best practices at Forbes since 2018 This voice experience is generated by AI. Learn more. This ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.